ArticleImmunoTargets and therapy2024

TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.

Xingchi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.